Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Sartorius AG. (3/28/19). "Press Release: Sartorius Supervisory Board Extends Appointment of Board Member Rainer Lehmann". Göttingen.

Organisation Organisation Sartorius AG
  Group Sartorius (Group)
Products Product laboratory equipment and instruments
  Product 2 bioreactor, disposable
Persons Person Lehmann, Rainer (Sartorius 201703–202310 CFO before SVP Business Processes Unit LEFT 11/24)
  Person 2 Kirchhoff, Petra (Sartorius 201401 VP Group Corporate Communications + IR)
     


At today’s meeting, the Supervisory Board of Sartorius AG passed the resolution to extend the appointment of Rainer Lehmann as a member of the Executive Board by a five-year period to February 28, 2025. Lehmann has been with Sartorius since 1999 with an interruption of about two years and has been a member of the Executive Board since March 2017. As such, he is responsible for Finance, Information Technology and Business Process.

Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn.


Current image files https://www.sartorius.com/en/company/newsroom/downloads-publications


Financial calendar

April 18, 2019 Publication of first-quarter figures for 2019
July 19, 2019 Publication of first-half figures for 2019
October 22, 2019 Publication of nine-month figures for 2019


A profile of Sartorius

The Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2018, the company earned sales revenue of some 1.57 billion euros. Currently, more than 8,100 people work at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.


Contact

Petra Kirchhoff | Head of Corporate Communications and Investor Relations
+49 (0)551.308.1686 | petra.kirchhoff@sartorius.com

   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Sartorius (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top